RecruitingPhase 3NCT04047628Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)Charlottesville, VA · Richmond, VA · +21 more sites
RecruitingPhase 1NCT03816345Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOSponsor: National Cancer Institute (NCI)Richmond, VA · +50 more sites
RecruitingPhase 3NCT06846281Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.Sponsor: Novartis PharmaceuticalsRichmond, VA · +43 more sites